Drugmaker Amgen discloses data breach involving patient health information
On July 29, Amgen determined the incident was material, based on its evaluation of how many files appeared to be affected and the possibility that the information in those files could be sensitive, it said in a regulatory filing.
We haven't written up this one. Economic Times Tech has the full story — the link below goes straight to it.

